UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Electrochemical detection of methyl-paraoxon based on bifunctional cerium oxide nanozyme with catalytic activity and signal amplification effect Journal article
Sun, Yuzhou#, Wei, Jinchao#, Zou, Jian, Cheng, Zehua, Huang, Zhongming, Gu, Liqiang, Zhong, Zhangfeng, Li, Shengliang, Wang, Yitao, Li, Peng. Electrochemical detection of methyl-paraoxon based on bifunctional cerium oxide nanozyme with catalytic activity and signal amplification effect[J]. Journal of Pharmaceutical Analysis, 2021, 11(5), 653-660.
Authors:  Sun, Yuzhou#;  Wei, Jinchao#;  Zou, Jian;  Cheng, Zehua;  Huang, Zhongming; et al.
Favorite | TC[WOS]:45 TC[Scopus]:44  IF:6.1/6.8 | Submit date:2021/09/13
Chinese Medicine  Electroanalysis  Methyl-paraoxon  Nanozyme  Organophosphorus  Pesticide  
Aligned Millineedle Arrays for Solar Power Seawater Desalination with Site-Specific Salt Formation Journal article
Huang, Zhongming#, Wei, Jinchao#, Wan, Yingpeng, Li, Peng, Yu, Jie, Dong, Jiayi, Wang, Shuangpeng, Li, Shengliang, Lee, Chun Sing. Aligned Millineedle Arrays for Solar Power Seawater Desalination with Site-Specific Salt Formation[J]. Small, 2021, 17(43), 2101487.
Authors:  Huang, Zhongming#;  Wei, Jinchao#;  Wan, Yingpeng;  Li, Peng;  Yu, Jie; et al.
Favorite | TC[WOS]:44 TC[Scopus]:45  IF:13.0/13.5 | Submit date:2021/09/17
Crystallization  Millineedle Array  Salt Harvesting  Solar Steam  Solar Water Purification  
Two-dimensional MXene-based materials for photothermal therapy Journal article
Huang,Zhongming, Cui,Xiao, Li,Shengliang, Wei,Jinchao, Li,Peng, Wang,Yitao, Lee,Chun Sing. Two-dimensional MXene-based materials for photothermal therapy[J]. Nanophotonics, 2020, 9(8), 2233-2249.
Authors:  Huang,Zhongming;  Cui,Xiao;  Li,Shengliang;  Wei,Jinchao;  Li,Peng; et al.
Favorite | TC[WOS]:87 TC[Scopus]:102  IF:6.5/7.4 | Submit date:2021/03/01
Mxenes  Photothermal Therapy  Synergistic Therapy  Two-dimensional Materials  
Determination of apatinib and its three active metabolites by UPLC-MS/MS in a Phase IV clinical trial in NSCLC patients Journal article
Guan, Shaoxing, Shi, Wei, Zhao, Zerui, Wang, Fei, Jiang, Fulin, Zhang, Caibin, Jin, Zhongming, Guan, Yanping, Liu, Dihan, Zhong, Guoping, Huang, Min, Long, Hao, Wang, Xueding. Determination of apatinib and its three active metabolites by UPLC-MS/MS in a Phase IV clinical trial in NSCLC patients[J]. Bioanalysis, 2019, 11(22), 2049-2060.
Authors:  Guan, Shaoxing;  Shi, Wei;  Zhao, Zerui;  Wang, Fei;  Jiang, Fulin; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:1.9/2.1 | Submit date:2022/05/23
Active Metabolites  Apatinib  Therapeutic Drug Monitoring  Uplc-ms/ms